Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02222350
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02222350
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02222350. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2014-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- 10mg DS-8500a tablet
- Intervention (Drug)
- 75mg DS-8500a tablet
- Intervention (Drug)
- placebo
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
Record details
- Record id
cardio:ct-nct02222350- Content hash
e5e1e3b306fec5784e790148571427362266527288089d569721f3f040df7850